VIVANI MEDICAL INC (VANI)

US92854B1098 - Common Stock

1.23  +0.02 (+1.65%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to VANI. VANI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While VANI seems to be doing ok healthwise, there are quite some concerns on its profitability. VANI is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

VANI had negative earnings in the past year.
In the past year VANI has reported a negative cash flow from operations.
VANI had negative earnings in each of the past 5 years.
VANI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

VANI has a Return On Assets of -47.18%. This is in the lower half of the industry: VANI underperforms 65.78% of its industry peers.
The Return On Equity of VANI (-88.38%) is worse than 65.78% of its industry peers.
Industry RankSector Rank
ROA -47.18%
ROE -88.38%
ROIC N/A
ROA(3y)-31.92%
ROA(5y)-126.35%
ROE(3y)-55.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

VANI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for VANI has been increased compared to 1 year ago.
Compared to 5 years ago, VANI has more shares outstanding
VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -2.19, we must say that VANI is in the distress zone and has some risk of bankruptcy.
VANI has a Altman-Z score of -2.19. This is in the lower half of the industry: VANI underperforms 63.64% of its industry peers.
VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.19
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

VANI has a Current Ratio of 5.13. This indicates that VANI is financially healthy and has no problem in meeting its short term obligations.
VANI's Current ratio of 5.13 is fine compared to the rest of the industry. VANI outperforms 68.98% of its industry peers.
VANI has a Quick Ratio of 5.13. This indicates that VANI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of VANI (5.13) is better than 74.33% of its industry peers.
Industry RankSector Rank
Current Ratio 5.13
Quick Ratio 5.13

More info and screens

0

3. Growth

3.1 Past

The earnings per share for VANI have decreased strongly by -33.38% in the last year.
EPS 1Y (TTM)-33.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

VANI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.92% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y5.66%
EPS Next 2Y-2.79%
EPS Next 3Y-4.8%
EPS Next 5Y-10.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VANI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VANI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

VANI's earnings are expected to decrease with -4.80% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.79%
EPS Next 3Y-4.8%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VANI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIVANI MEDICAL INC

NASDAQ:VANI (7/5/2024, 7:22:59 PM)

1.23

+0.02 (+1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap67.63M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.18%
ROE -88.38%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.13
Quick Ratio 5.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-33.38%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y5.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y